Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. - Test2 - elhamkhani - TriplyDB

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.

http://www.wikidata.org/entity/Q34184711

about

DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination A Reverse Genetics Platform That Spans the Zika Virus Family Tree Dengue fever virus in Pakistan: effects of seasonal pattern and temperature change on distribution of vector and virus.Next generation sequencing of DNA-launched Chikungunya vaccine virus.Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys.A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine Evolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization.An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.Dengue viruses cluster antigenically but not as discrete serotypes Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.Serotype-specific host responses in rhesus macaques after primary dengue challenge.Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone Construction and characterisation of a complete reverse genetics system of dengue virus type 3.The human antibody response to dengue virus infection Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone.The relevance of dengue virus genotypes surveillance at country level before vaccine approval.Immune correlates of protection for dengue: State of the art and research agenda.Dengue vaccines: what we know, what has been done, but what does the future hold?The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.Intrahost Selection Pressures Drive Rapid Dengue Virus Microevolution in Acute Human Infections.Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses.Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.Dengue infection.Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection.An Immunocompetent Mouse Model of Zika Virus Infection.

P2860

Q24701765-90D607CF-24A6-43B8-AC8A-878B0E24390B Q28114614-2FDD0600-6281-490C-8DA6-38A6630C41D4 Q28954816-D1B6FEC4-15C3-4777-ADF2-B6E5D2BCE7CD Q30245613-4F321EE5-BAE6-463F-871C-671D591A97F4 Q30384231-C574E42D-B53A-4D22-A5D8-B8BA37BBA252 Q34615061-C4B5373B-7EE2-4FFD-A532-B38C867E6390 Q35548048-A960D042-45B0-4553-A132-68B24256F372 Q36205859-B201DACF-B6D8-43E1-85E6-5351311D40E1 Q36286276-750D6FDE-EE5B-4C7E-B882-0861FB1F9BDB Q36565486-09F3EC9D-26DD-4885-83F9-6266A4F0A572 Q36597801-7F5BFBE4-89C4-4A76-836D-89660BF6C063 Q36667964-F70F24C0-7510-44FF-82B5-0266A60993D7 Q36878970-3C8D74EE-BC15-49C5-934F-B538E24051B0 Q36926525-72662B6A-A92B-4B5C-9AE5-D2D5A82457AF Q37265013-AAF6B051-2069-46E2-9F4B-956F30B1C597 Q37372592-CDEDA41F-EC1E-4BC1-BAE6-0102CC2CD51D Q37571377-14CD37D7-46DF-4D5E-BDC6-001B9E30CA74 Q37661008-41ADADA8-CDDB-4126-A604-195EB8DEE785 Q37734118-32F1909C-C309-4650-AC96-C63DBC0F8F95 Q37987124-8C6CF02A-ED81-4673-9509-6BB890FC794E Q38158434-D696D610-E98D-4C1E-B8A2-BBEDD7D9B7F8 Q38284671-3A08A626-9297-4890-A28F-9230E812D7A4 Q38652971-7379F480-3B7F-49F0-934E-7231314A4DE1 Q38960985-BEE1E8D3-7F5B-4F3B-B05C-BA5272C32E64 Q39186657-B4E9383B-298E-49DC-9534-81B9D0A4CB47 Q40038877-A8D0194A-2F4D-4A07-AFE6-C7E183DD143D Q40200075-E8B2FC6C-5D44-4B7A-977A-245BD710D083 Q41676281-56DE2190-A7B2-4A51-A4CE-4F5355D1E79C Q42996339-EE796441-3EBA-4F99-981A-6ABDA4F1C27A Q43038900-50DAE6E5-FD64-4560-AB8A-88B9637D7462 Q45323668-EC9EBA79-3162-4424-9005-2422D38DCF66 Q51782689-BDC3D762-FE66-4042-8916-348407AD1646 Q55084484-D75846EC-10AF-40BA-81BC-9174329E81BB

P2860

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.

http://www.wikidata.org/entity/Q34184711

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Development and characterizati ...... variation and neutralization.

@ast

Development and characterizati ...... variation and neutralization.

@en

Development and characterizati ...... variation and neutralization.

@nl

type

label

Development and characterizati ...... variation and neutralization.

@ast

Development and characterizati ...... variation and neutralization.

@en

Development and characterizati ...... variation and neutralization.

@nl

prefLabel

Development and characterizati ...... variation and neutralization.

@ast

Development and characterizati ...... variation and neutralization.

@en

Development and characterizati ...... variation and neutralization.

@nl

P1433

Q34184711-5FED47B3-C152-4B3F-AB98-46B87AC67E15

P1476

Q34184711-5BE3C88A-7E5C-4DBB-8F4A-530D2B5CCD35

P2093

Q34184711-3EF0B2BB-A371-4372-9FB3-8A08B3ADD0D6

Q34184711-542AFA98-3B90-4F95-BEDE-F60BC5839003

Q34184711-F1642C32-ED5D-4926-A5D4-0627B0F7035C

Q34184711-F401F37F-E8A0-4CDE-A272-89B5F9D37918

Q34184711-F49C12F8-8DC3-4EC1-ABA1-9C13FD91A1C0

P2860

Q34184711-04892609-AC84-40D2-8BE4-AABDC8DAEAD2

Q34184711-06004889-EA3A-4B17-B580-369F6318D1C9

Q34184711-082C4877-857E-455C-B4D0-F55D418CF849

Q34184711-0DC1C58E-ABF0-4046-B065-46C8D7BF572C

Q34184711-0F62F97B-A046-4C57-9503-3825887E6FF3

Q34184711-10FD8EAA-0A3A-48F3-A815-689C9818CE5A

Q34184711-1153F229-9D77-4125-9272-E04C7AACE22C

Q34184711-1343D5E3-1DCB-433D-A8A0-F6D69FFF9FAB

Q34184711-18B5E110-CDED-4A8E-AAD5-A41D9CC6E744

Q34184711-1CCCC40B-A741-4B1F-A6AE-0D87C54EF4E9

P304

Q34184711-0AFE051E-EEF4-4E42-9900-856AD4F8DFCD

P31

Q34184711-1D27713F-0BE5-4C13-B5E3-B5B836EA8285

P356

Q34184711-D1504BE5-88B0-47B3-B677-19DAE9086469

P407

Q34184711-552FFB3D-5785-4AFD-B280-A119793EB24D

P433

Q34184711-35DCDB53-E9E3-448D-853A-CC2B3C66C4E0

P478

Q34184711-6C8E5CE4-B304-4B23-8871-838DCD8C7C75

P50

Q34184711-C8DD5D99-B509-4917-9632-4189B698FC52

Q34184711-F8C8A0D3-2C7E-4C4E-9E69-E7E0341239F8

P577

Q34184711-52BF50A7-5F19-47E1-9AC1-6722D518FC65

P5875

Q34184711-BC839D62-F9B0-4D9B-80C2-B118C954066D

P698

Q34184711-0E44D73E-24ED-4148-AAD0-C82F83F67878

P921

Q34184711-2A6D440B-D937-4718-B8C0-992E349F261E

P932

Q34184711-8434C661-C7DA-4A0C-A6B3-28E295C91C81

P356

JOURNAL.PNTD.0001486

P1433

PLOS Neglected Tropical Diseases

P1476

Development and characterizati ...... variation and neutralization.

@en

P2093

Boyd Yount

http://www.w3.org/2001/XMLSchema#string

Eric F Donaldson

http://www.w3.org/2001/XMLSchema#string

Jeremy P Huynh

http://www.w3.org/2001/XMLSchema#string

Kari E Hacker

http://www.w3.org/2001/XMLSchema#string

William B Messer

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sequence alignment with the Clustal series of programs

Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease

Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine

Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence

A ligand-binding pocket in the dengue virus envelope glycoprotein

P304

e1486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0001486

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Aravinda de Silva

P577

2012-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221887445

http://www.w3.org/2001/XMLSchema#string

P698

22389731

http://www.w3.org/2001/XMLSchema#string

P921

P932

3289595

http://www.w3.org/2001/XMLSchema#string